An integrated workflow for proteome-wide off-target identification and polypharmacology drug design

Tsinghua Science and Technology

Volumn 19, Issue 3, 2014, Pages 275-284

  Evangelidis, Thomas ^a   Xie, Lei ^b  

^a UNIVERSITY OF ATHENS   (Greece)

^b City College of New York   (United States)

Author keywords

drug discovery; off target; polypharmacology; structural proteomics; systems biology

Indexed keywords

MOLECULAR BIOLOGY;

DRUG DISCOVERY; OFF-TARGET; POLYPHARMACOLOGY; PROTEOMICS; SYSTEMS BIOLOGY;

BINDING SITES;

EID: 84902801533     PISSN: 10070214     EISSN: None     Source Type: Journal    
DOI: 10.1109/TST.2014.6838198     Document Type: Article

References (48)

1. L. Xie, L. Xie, S. L. Kinnings, and P. E. Bourne,Novel computational approaches to polypharmacologyas a means to define responses to individual drugs,Annu. Rev. Pharmacol. Toxicol., vol. 52, pp. 361-379,2012.
2. E. L. Tobinick, The value of drug repositioning in thecurrent pharmaceutical market, Drug News Perspect.,vol. 22, no. 2, pp. 119-125, Mar. 2009.
3. H. M. Berman, J. Westbrook, Z. Feng, G. Gilliland,T. N. Bhat, H.Weissig, I. N. Shindyalov, and P. E. Bourne,The protein data bank, Nucleic Acids Res., vol. 28, no. 1,pp. 235-242, Jan. 2000. (Pubitemid 30047768)
4. D. S. Wishart, C. Knox, A. C. Guo, D. Cheng,S. Shrivastava, D. Tzur, B. Gautam, and M. Hassanali,DrugBank: A knowledgebase for drugs, drug actions anddrug targets, Nucleic Acids Res., vol. 36, no. Databaseissue, pp. D901-906, Jan. 2008. (Pubitemid 351149842)
5. B. Chen, D. Wild, and R. Guha, PubChem as a source ofpolypharmacology, J. Chem. Inf. Model., vol. 49, no. 9,pp. 2044-2055, Sep. 2009.
6. Y. Wang, J. Xiao, T. O. Suzek, J. Zhang, J. Wang, andS. H. Bryant, PubChem: A public information systemfor analyzing bioactivities of small molecules, NucleicAcids Res., vol. 37, no. Web Server issue, pp. W623-633,Jul. 2009.
7. A. Gaulton, L. J. Bellis, A. P. Bento, J. Chambers,M. Davies, A. Hersey, Y. Light, S. McGlinchey,D. Michalovich, B. Al-Lazikani, and J. P. Overington,ChEMBL: A large-scale bioactivity database for drugdiscovery, Nucleic Acids Res., vol. 40, no. Database issue,pp. D1100-1107, Jan. 2012.
8. M. J. Keiser, B. L. Roth, B. N. Armbruster, P. Ernsberger,J. J. Irwin, and B. K. Shoichet, Relating proteinpharmacology by ligand chemistry, Nat. Biotechnol.,vol. 25, no. 2, pp. 197-206, Feb. 2007. (Pubitemid 46227119)
9. M. J. Keiser, V. Setola, J. J. Irwin, C. Laggner,A. I. Abbas, S. J. Hufeisen, N. H. Jensen, M. B. Kuijer,R. C. Matos, T. B. Tran, R. Whaley, R. A. Glennon, J. Hert,K. L. H. Thomas, D. D. Edwards, B. K. Shoichet, andB. L. Roth, Predicting new molecular targets for knowndrugs, Nature, vol. 462, no. 7270, pp. 175-181, Nov. 2009.
10. F. Iorio, R. Tagliaferri, and D. di Bernardo, Identifyingnetwork of drug mode of action by gene expressionprofiling, J. Comput. Biol., vol. 16, no. 2, pp. 241-251,Feb. 2009.
11. M. Campillos, M. Kuhn, A.-C. Gavin, L. J. Jensen,and P. Bork, Drug target identification using side-effectsimilarity, Science, vol. 321, no. 5886, pp. 263-266,Jul. 2008. (Pubitemid 351989100)
12. L. Xie, L. Xie, and P. E. Bourne, Structure-basedsystems biology for analyzing off-target binding,Curr. Opin. Struct. Biol., vol. 21, no. 2, pp. 189-199,Apr. 2011.
13. S. L. Kinnings, N. Liu, N. Buchmeier, P. J. Tonge, L. Xie,and P. E. Bourne, Drug discovery using chemical systemsbiology: Repositioning the safe medicine Comtan to treatmulti-drug and extensively drug resistant tuberculosis,PLoS Comput. Biol., vol. 5, no. 7, p. e1000423, Jul. 2009.
14. S. J. Ho Sui, R. Lo, A. R. Fernandes, M. D. G. Caulfield,J. A. Lerman, L. Xie, P. E. Bourne, D. L. Baillie, andF. S. L. Brinkman, Raloxifene attenuates Pseudomonasaeruginosa pyocyanin production and virulence,Int. J. Antimicrob. Agents, vol. 40, no. 3, pp. 246-251,Sep. 2012.
15. J. D. Durrant, R. E. Amaro, L. Xie, M. D. Urbaniak,M. A. J. Ferguson, A. Haapalainen, Z. Chen, A. M. DiGuilmi, F.Wunder, P. E. Bourne, and J. A. McCammon, Amultidimensional strategy to detect polypharmacologicaltargets in the absence of structural and sequence homology,PLoS Comput. Biol., vol. 6, no. 1, p. e1000648, Jan. 2010.
16. L. Xie, J. Wang, and P. E. Bourne, In silico elucidationof the molecular mechanism defining the adverseeffect of selective estrogen receptor modulators, PLoSComput. Biol., vol. 3, no. 11, p. e217, Nov. 2007.
17. L. Xie, J. Li, L. Xie, and P. E. Bourne, Drug discoveryusing chemical systems biology: Identification of theprotein-ligand binding network to explain the side effectsof CETP inhibitors, PLoS Comput. Biol., vol. 5, no. 5,p. e1000387, May 2009.
18. L. Xie, T. Evangelidis, L. Xie, and P. E. Bourne,Drug discovery using chemical systems biology: Weakinhibition of multiple kinases may contribute to the anticancereffect of nelfinavir, PLoS Comput. Biol., vol. 7,no. 4, p. e1002037, Apr. 2011.
19. R. L. Chang, L. Xie, L. Xie, P. E. Bourne, and B. ø. Palsson,Drug off-target effects predicted using structural analysisin the context of a metabolic network model, PLoSComput. Biol., vol. 6, no. 9, p. e1000938, 2010.
20. S. L. Kinnings, L. Xie, K. H. Fung, R. M. Jackson,L. Xie, and P. E. Bourne, The Mycobacterium tuberculosisdrugome and its polypharmacological implications, PLoSComput. Biol., vol. 6, no. 11, p. e1000976, 2010.
21. L. Xie and P. E. Bourne, A robust and efficient algorithmfor the shape description of protein structures and itsapplication in predicting ligand binding sites, BMCBioinformatics, vol. 8, no. Suppl 4, p. S9, 2007.
22. L. Xie and P. E. Bourne, Detecting evolutionaryrelationships across existing fold space, usingsequence order-independent profile-profile alignments,Proc. Natl. Acad. Sci. USA, vol. 105, no. 14, pp. 5441-5446, Apr. 2008. (Pubitemid 351753882)
23. L. Xie, L. Xie, and P. E. Bourne, A unified statistical modelto support local sequence order independent similaritysearching for ligand-binding sites and its application togenome-based drug discovery, Bioinforma. Oxf. Engl.,vol. 25, no. 12, pp. i305-312, Jun. 2009.
24. N. A. Baker, D. Sept, S. Joseph, M. J. Holst, andJ. A. McCammon, Electrostatics of nanosystems:Application to microtubules and the ribosome,Proc. Natl. Acad. Sci. USA, vol. 98, no. 18, pp. 10037-10041, Aug. 2001.
25. A. N. Jain, Surflex-Dock 2.1: Robust performance fromligand energetic modeling, ring flexibility, and knowledgebasedsearch, J. Comput. Aided Mol. Des., vol. 21, no. 5,pp. 281-306, May 2007. (Pubitemid 46630055)
26. G. M. Morris, D. S. Goodsell, R. S. Halliday, R. Huey,W. E. Hart, R. K. Belew, and A. J. Olson, Automateddocking using a Lamarckian genetic algorithm and anempirical binding free energy function, J. Comput. Chem.,vol. 19, no. 14, pp. 1639-1662, Nov. 1998. (Pubitemid 128590223)
27. O. Trott and A. J. Olson, AutoDock Vina: Improvingthe speed and accuracy of docking with a new scoringfunction, efficient optimization, and multithreading,J. Comput. Chem., vol. 31, no. 2, pp. 455-461, 2010.
28. J. R. Miller, S. Dunham, I. Mochalkin, C. Banotai,M. Bowman, S. Buist, B. Dunkle, D. Hanna,H. J. Harwood, M. D. Huband, A. Karnovsky, M. Kuhn,C. Limberakis, J. Y. Liu, S. Mehrens, W. T. Mueller,L. Narasimhan, A. Ogden, J. Ohren, J. V. N. V. Prasad,J. A. Shelly, L. Skerlos, M. Sulavik, V. H. Thomas,S. VanderRoest, L. Wang, Z. Wang, A. Whitton, T. Zhu,and C. K. Stover, A class of selective antibacterialsderived from a protein kinase inhibitor pharmacophore,Proc. Natl. Acad. Sci. USA, vol. 106, no. 6, pp. 1737-1742,Feb. 2009.
29. O. Guvench and A. D. MacKerell Jr, Computationalevaluation of protein-small molecule binding,Curr. Opin. Struct. Biol., vol. 19, no. 1, pp. 56-61,Feb. 2009.
30. G. Carta, A. J. S. Knox, and D. G. Lloyd, Unbiasingscoring functions: A new normalization and rescoringstrategy, J. Chem. Inf. Model., vol. 47, no. 4, pp. 1564-1571, Aug. 2007. (Pubitemid 47210059)
31. J. J. Irwin and B. K. Shoichet, ZINC-A free database ofcommercially available compounds for virtual screening,J. Chem. Inf. Model., vol. 45, no. 1, pp. 177-182, Feb. 2005. (Pubitemid 40736970)
32. A. Bairoch, R. Apweiler, C. H. Wu, W. C. Barker,B. Boeckmann, S. Ferro, E. Gasteiger, H. Huang,R. Lopez, M. Magrane, M. J. Martin, D. A. Natale,C. ODonovan, N. Redaschi, and L.-S. L. Yeh, Theuniversal protein resource (UniProt), Nucleic Acids Res.,vol. 33, no. Database issue, pp. D154-159, Jan. 2005. (Pubitemid 40207850)
33. J. M. Fernndez, R. Hoffmann, and A. Valencia, iHOP webservices, Nucleic Acids Res., vol. 35, no.Web Server issue,pp. W21-26, Jul. 2007.
34. A. Schlicker and M. Albrecht, FunSimMat: Acomprehensive functional similarity database, NucleicAcids Res., vol. 36, no. Database issue, pp. D434-439,Jan. 2008. (Pubitemid 351149762)
35. J. J. Gills, J. Lopiccolo, J. Tsurutani, R. H. Shoemaker,C. J. M. Best, M. S. Abu-Asab, J. Borojerdi, N. A. Warfel,E. R. Gardner, M. Danish, M. C. Hollander, S. Kawabata,M. Tsokos, W. D. Figg, P. S. Steeg, and P. A. Dennis,Nelfinavir, a lead HIV protease inhibitor, is a broadspectrum,anticancer agent that induces endoplasmicreticulum stress, autophagy, and apoptosis in vitro and invivo, Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res.,vol. 13, no. 17, pp. 5183-5194, Sep. 2007. (Pubitemid 47502088)
36. J. J. Gills, J. Lopiccolo, and P. A. Dennis, Nelfinavir, anew anti-cancer drug with pleiotropic effects and manypaths to autophagy, Autophagy, vol. 4, no. 1, pp. 107-109,Jan. 2008.
37. N. Pore, A. K. Gupta, G. J. Cerniglia, and A. Maity, HIVprotease inhibitors decrease VEGF/HIF-1alpha expressionand angiogenesis in glioblastoma cells, Neoplasia N. Y. N,vol. 8, no. 11, pp. 889-895, Nov. 2006.
38. K. C. Cuneo, T. Tu, L. Geng, A. Fu, D. E. Hallahan, andC. D. Willey, HIV protease inhibitors enhance the efficacyof irradiation, Cancer Res., vol. 67, no. 10, pp. 4886-4893,May 2007. (Pubitemid 46910197)
39. J. P. Plastaras, N. Vapiwala, M. S. Ahmed, D. Gudonis,G. J. Cerniglia, M. D. Feldman, I. Frank, and A. K. Gupta,Validation and toxicity of PI3K/Akt pathway inhibition byHIV protease inhibitors in humans, Cancer Biol. Ther.,vol. 7, no. 5, pp. 628-635, May 2008.
40. J. D. Carpten, A. L. Faber, C. Horn, G. P. Donoho,S. L. Briggs, C. M. Robbins, G. Hostetter, S. Boguslawski,T. Y. Moses, S. Savage, M. Uhlik, A. Lin, J. Du, Y.-W. Qian, D. J. Zeckner, G. Tucker-Kellogg, J. Touchman,K. Patel, S. Mousses, M. Bittner, R. Schevitz, M.-H. T. Lai,K. L. Blanchard, and J. E. Thomas, A transformingmutation in the pleckstrin homology domain of AKT1 incancer, Nature, vol. 448, no. 7152, pp. 439-444, Jul. 2007. (Pubitemid 47123510)
41. Q. Meng, C. Xia, J. Fang, Y. Rojanasakul, and B.-H. Jiang,Role of PI3K and AKT specific isoforms in ovarian cancercell migration, invasion and proliferation through thep70S6K1 pathway, Cell. Signal., vol. 18, no. 12, pp. 2262-2271, Dec. 2006. (Pubitemid 44636166)
42. X. Ju, S. Katiyar, C. Wang, M. Liu, X. Jiao, S. Li,J. Zhou, J. Turner, M. P. Lisanti, R. G. Russell,S. C. Mueller, J. Ojeifo, W. S. Chen, N. Hay, andR. G. Pestell, Akt1 governs breast cancer progression invivo, Proc. Natl. Acad. Sci. USA, vol. 104, no. 18, pp. 7438-7443, May 2007. (Pubitemid 47185924)
43. Z. Q. Yuan, M. Sun, R. I. Feldman, G. Wang, X. Ma,C. Jiang, D. Coppola, S. V. Nicosia, and J. Q. Cheng,Frequent activation of AKT2 and induction of apoptosis byinhibition of phosphoinositide-3-OH kinase/Akt pathwayin human ovarian cancer, Oncogene, vol. 19, no. 19,pp. 2324-2330, May 2000. (Pubitemid 30307208)
44. A. Faridmoayer, M. A. Fentabil, M. F. Haurat, W. Yi,R. Woodward, P. G. Wang, and M. F. Feldman, Extremesubstrate promiscuity of the Neisseria oligosaccharyltransferase involved in protein O-glycosylation,J. Biol. Chem., vol. 283, no. 50, pp. 34596-34604,Dec. 2008.
45. S. Tanno, S. Tanno, Y. Mitsuuchi, D. A. Altomare,G. H. Xiao, and J. R. Testa, AKT activation upregulatesinsulin-like growth factor I receptor expressionand promotes invasiveness of human pancreatic cancercells, Cancer Res., vol. 61, no. 2, pp. 589-593, Jan. 2001. (Pubitemid 32128619)
46. X. H. Shi, Z. Y. Liang, X. Y. Ren, and T. H. Liu, Combinedsilencing of K-ras and Akt2 oncogenes achieves synergisticeffects in inhibiting pancreatic cancer cell growth in vitroand in vivo, Cancer Gene Ther., vol. 16, no. 3, pp. 227-236,Mar. 2009.
47. L. Castagnoli, A. Costantini, C. DallArmi, S. Gonfloni,L. Montecchi-Palazzi, S. Panni, S. Paoluzi, E. Santonico,and G. Cesareni, Selectivity and promiscuity in theinteraction network mediated by protein recognitionmodules, FEBS Lett., vol. 567, no. 1, pp. 74-79, Jun. 2004. (Pubitemid 38686426)
48. A. K. Gupta, G. J. Cerniglia, R. Mick, W. G. McKenna,and R. J. Muschel, HIV protease inhibitors block Aktsignaling and radiosensitize tumor cells both in vitro andin vivo, Cancer Res., vol. 65, no. 18, pp. 8256-8265,Sep. 2005. (Pubitemid 41330590)